European Radiology

, Volume 27, Issue 7, pp 3080–3087 | Cite as

Gd-EOB-DTPA-enhanced MRI for monitoring future liver remnant function after portal vein embolization and extended hemihepatectomy: A prospective trial

  • Dominik GeiselEmail author
  • Philip Raabe
  • Lutz Lüdemann
  • Maciej Malinowski
  • Martin Stockmann
  • Daniel Seehofer
  • Johann Pratschke
  • Bernd Hamm
  • Timm Denecke



To evaluate changes in liver function after right portal vein embolization (PVE) and extended right hemihepatectomy using gadolinium ethoxybenzyl-DTPA-enhanced (Gd-EOB-DTPA) MRI.


In this prospective trial, 37 patients undergoing PVE were examined before and 14 and 28 days after PVE and 10 days after extended hemihepatectomy using Gd-EOB-DTPA-enhanced MRI. Lobar volume, kinetic growth rate (KGR), relative enhancement (RE) as well as hepatocellular uptake index (HUI) and fat signal fraction (FSF) were calculated for each lobe.


RE of the left liver lobe (LLL) was steadily increasing after PVE and decreased to 0.48 ± 0.19 10 days after surgery, which is significantly lower than 14 days and 28 days post PVE (P < 0.05). KGR was 14.06 ± 9.82%/week for the period from PVE to 14 days after PVE. HUI of the LLL increased steadily after PVE and was significantly higher at both 14 and 28 days after PVE compared to pre PVE (P < 0.05). HUI of the residual liver after surgery was lower than before.


Gd-EOB-DTPA-enhanced MRI may be used to monitor the functional increase in the FLR after PVE and to depict the intraoperative liver injury leading to a decrease in liver remnant function.

Key Points

• The most significant FLR volume increase happens within the first 14 days.

• No MRI parameter was able to predict the success of FLR growth.

• Our data suggest an early resection about 14 days after PVE.

• Routine Gd-EOB-DTPA-enhanced MRI might be suitable to replace ICG-test.


Liver Portal vein embolization Gadolinium ethoxybenzyl DTPA Liver function tests Magnetic resonance imaging 

Abbreviations and acronyms


Fat signal fraction


Future liver remnant


Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid


Hepatic uptake index


Indocyanine green


Kinetic growth rate


Maximum liver function capacity


Left liver lobe


Portal vein embolisation


Relative enhancement


Right liver lobe


Region of interest


Signal intensity


Volume interpolated breath-hold examination



The scientific guarantor of this publication is Dominik Geisel. The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. The authors state that this work has not received any funding. One of the authors has significant statistical expertise. Institutional Review Board approval was obtained. Written informed consent was waived by the Institutional Review Board. Some study subjects or cohorts have been previously reported in European Radiology. Methodology: prospective, observational/experimental, performed at one institution


  1. 1.
    Abdalla EK, Hicks ME, Vauthey JN (2001) Portal vein embolization: rationale, technique and future prospects. Br J Surg 88:165–175CrossRefPubMedGoogle Scholar
  2. 2.
    Farges O, Belghiti J, Kianmanesh R et al (2003) Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 237:208PubMedPubMedCentralGoogle Scholar
  3. 3.
    Nagino M, Kamiya J, Nishio H et al (2006) Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg 243:364–372CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Madoff DC, Gaba RC, Weber CN et al (2016) Portal venous interventions: state of the art. Radiology 278:333–353CrossRefPubMedGoogle Scholar
  5. 5.
    Ribero D, Abdalla EK, Madoff DC et al (2007) Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 94:1386–1394CrossRefPubMedGoogle Scholar
  6. 6.
    Vauthey J-N, Abdalla EK, Doherty DA et al (2002) Body surface area and body weight predict total liver volume in Western adults. Liver Transpl 8:233–240CrossRefPubMedGoogle Scholar
  7. 7.
    van Lienden KP, van den Esschert JW, de Graaf W et al (2012) Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol 36:25–34CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Vauthey JN, Chaoui A, Do KA et al (2000) Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 127:512–519CrossRefPubMedGoogle Scholar
  9. 9.
    Hemming AW, Reed AI, Howard RJ et al (2003) Preoperative portal vein embolization for extended hepatectomy. Ann Surg 237:686–91– discussion 691–3Google Scholar
  10. 10.
    Sato Y, Matsushima S, Inaba Y et al (2015) Preoperative estimation of future remnant liver function following portal vein embolization using relative enhancement on gadoxetic acid disodium-enhanced magnetic resonance imaging. Korean J Radiol 16:523–530CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Fazakas J, Mándli T, Ther G et al (2006) Evaluation of liver function for hepatic resection. Transplant Proc 38:798–800CrossRefPubMedGoogle Scholar
  12. 12.
    Stockmann M, Lock JF, Riecke B et al (2009) Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Ann Surg 250:119–125CrossRefPubMedGoogle Scholar
  13. 13.
    de Graaf W, van Lienden KP, Dinant S et al (2010) Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection. J Gastrointest Surg 14:369–378CrossRefPubMedGoogle Scholar
  14. 14.
    de Graaf W, van Lienden KP, van den Esschert JW et al (2011) Increase in future remnant liver function after preoperative portal vein embolization. Br J Surg 98:825–834CrossRefPubMedGoogle Scholar
  15. 15.
    Geisel D, Lüdemann L, Keuchel T et al (2013) Increase in left liver lobe function after preoperative right portal vein embolisation assessed with gadolinium-EOB-DTPA MRI. Eur Radiol 23:2555–2560. doi: 10.1007/s00330-013-2859-1
  16. 16.
    Akiba A, Murata S, Mine T et al (2014) Volume change and liver parenchymal signal intensity in Gd-EOB-DTPA-enhanced magnetic resonance imaging after portal vein embolization prior to hepatectomy. Biomed Res Int 2014:684754–684757CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Saito K, Ledsam J, Sourbron S et al (2013) Assessing liver function using dynamic Gd-EOB-DTPA-enhanced MRI with a standard 5-phase imaging protocol. J Magn Reson Imaging 37:1109–1114CrossRefPubMedGoogle Scholar
  18. 18.
    Verloh N, Haimerl M, Zeman F et al (2014) Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla. Eur Radiol 24:1013–1019CrossRefPubMedGoogle Scholar
  19. 19.
    Geisel D, Lüdemann L, Hamm B, Denecke T (2015) Imaging-based liver function tests - past, present and future. Rofo. doi: 10.1055/s-0035-1553306 PubMedGoogle Scholar
  20. 20.
    Shindoh J, Truty MJ, Aloia TA et al (2013) Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg 216:201–209CrossRefPubMedGoogle Scholar
  21. 21.
    Yoshimitsu K, Kuroda Y, Nakamuta M et al (2008) Noninvasive estimation of hepatic steatosis using plain CT vs. chemical-shift MR imaging: significance for living donors. J Magn Reson Imaging 28:678–684CrossRefPubMedGoogle Scholar
  22. 22.
    Robles R, Marín C, Lopez-Conesa A et al (2012) Comparative study of right portal vein ligation versus embolisation for induction of hypertrophy in two-stage hepatectomy for multiple bilateral colorectal liver metastases. Eur J Surg Oncol 38:586–593CrossRefPubMedGoogle Scholar
  23. 23.
    Wakabayashi H, Ishimura K, Okano K et al (2002) Application of preoperative portal vein embolization before major hepatic resection in patients with normal or abnormal liver parenchyma. Surgery 131:26–33CrossRefPubMedGoogle Scholar
  24. 24.
    de Graaf W, Bennink RJ, Heger M et al (2011) Quantitative assessment of hepatic function during liver regeneration in a standardized rat model. J Nucl Med 52:294–302CrossRefPubMedGoogle Scholar
  25. 25.
    Uesaka K, Nimura Y, Nagino M (1996) Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg 223:77–83CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Haimerl M, Verloh N, Fellner C et al (2014) MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score. Sci Rep 4:5621. doi: 10.1038/srep05621
  27. 27.
    Michaely HJ, Morelli JN, Budjan J et al (2013) CAIPIRINHA-Dixon-TWIST (CDT)-volume-interpolated breath-hold examination (VIBE): a new technique for fast time-resolved dynamic 3-dimensional imaging of the abdomen with high spatial resolution. Invest Radiol 48:590–597CrossRefPubMedGoogle Scholar
  28. 28.
    Neri E, Bali MA, Ba-Ssalamah A et al (2016) ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents. Eur Radiol 26:921–931CrossRefPubMedGoogle Scholar
  29. 29.
    Haimerl M, Schlabeck M, Verloh N et al (2015) Volume-assisted estimation of liver function based on Gd-EOB-DTPA-enhanced MR relaxometry. Eur Radiol :1–9. doi: 10.1007/s00330-015-3919-5
  30. 30.
    Nilsson H, Blomqvist L, Douglas L et al (2010) Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI. HPB (Oxford) 12:567–576CrossRefGoogle Scholar
  31. 31.
    Nilsson H, Blomqvist L, Douglas L, et al (2013) Gd-EOB-DTPA-enhanced MRI for the assessment of liver function and volume in liver cirrhosis. Br J Radiol 86:20120653. doi: 10.1259/bjr.20120653
  32. 32.
    Nuzzo G, Giuliante F, Giovannini I et al (2001) Liver resections with or without pedicle clamping. Am J Surg 181:238–246CrossRefPubMedGoogle Scholar
  33. 33.
    Malinowski M, Lock JF, Seehofer D, et al (2015) Preliminary study on liver function changes after trisectionectomy with versus without prior portal vein embolization. Surg Today :1–9. doi: 10.1007/s00595-015-1293-1
  34. 34.
    Matoori S, Froehlich JM, Breitenstein S et al (2016) Age dependence of spleen- and muscle-corrected hepatic signal enhancement on hepatobiliary phase gadoxetate MRI. Eur Radiol 26:1889–1894CrossRefPubMedGoogle Scholar
  35. 35.
    Gschwend S, Ebert W, Schultze-Mosgau M, Breuer J (2011) Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment. Invest Radiol 46:556–566CrossRefPubMedGoogle Scholar
  36. 36.
    Talakic E, Steiner J, Kalmar P et al (2014) Gd-EOB-DTPA enhanced MRI of the liver: correlation of relative hepatic enhancement, relative renal enhancement, and liver to kidneys enhancement ratio with serum hepatic enzyme levels and eGFR. Eur J Radiol 83:607–611CrossRefPubMedGoogle Scholar
  37. 37.
    Leonhardt M, Keiser M, Oswald S et al (2010) Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters. Drug Metab Dispos 38:1024–1028CrossRefPubMedGoogle Scholar
  38. 38.
    Pascolo L, Cupelli F, Anelli PL et al (1999) Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents. Biochem Biophys Res Commun 257:746–752CrossRefPubMedGoogle Scholar

Copyright information

© European Society of Radiology 2016

Authors and Affiliations

  1. 1.Department of Diagnostic and Interventional RadiologyCharité Campus Virchow-KlinikumBerlinGermany
  2. 2.Department of General, Visceral and Transplantation SurgeryCharité Campus Virchow-KlinikumBerlinGermany
  3. 3.Department of Medical PhysicsEssen University HospitalEssenGermany

Personalised recommendations